Uterine Fibroid Embolization Survey in Canada: Challenges, Opportunities, and Differences in Practices Across the Country
Canadian Association of Radiologists Journal · 2024
DOI: 10.1177/08465371241252307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Association of Radiologists Journal, 2024. Verfasst von Pierre-Luc Gagnon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada. Hauptthemen laut MEDLINE: Practice Patterns, Physicians', Leiomyoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To assess the current practices surrounding Uterine Fibroid Embolization (UFE) in Canada.
Methods
An online survey was sent to Canadian Association for Interventional Radiology (CAIR) members. It included questions on symptoms prompting UFE, patient awareness, investigation, UFE settings, the number of UFE procedures, and post-UFE care. The findings were discussed at CAIR’s 2023 annual meeting by an expert panel.
Results
Out of 792 surveys sent, 87 were filled (11%). Menorrhagia is the most common indication for UFE (87%). Women’s awareness of UFE as a treatment option for fibroids is viewed as poor or average by 94% of our survey respondents. Most respondents see patients in clinics (92%) before the procedure and evaluate fibroids with MRI pre-UFE (76%). There is variability in care post-UFE, with 33% of procedures being performed as day surgery while 67% lead to overnight stay. For pain management, intravenous analgesia (including patient-controlled analgesia) is used in 76% (63/83) of cases while 19% (16/83) of respondents mentioned using epidural analgesia. Finally, there is an even split between embolic agent used; non-spherical polyvinyl alcohol (50%) and spherical particles (50%).
Conclusion
Respondents believe patients in Canada still have limited awareness of UFE. Interventional radiologists are increasingly involved in the entire patient care trajectory, overseeing pre-and post-procedure care and hospitalizing patients. For pain management after UFE, it is observed that while epidural analgesia has been demonstrated more effective than alternatives, it is not widely used as the primary method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
- Faculté de médecine, Département de radiologie, radio-oncologie et médecine nucléaire, Université de Montréal, Montréal, QC, Canada.
- Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
- Centre intégré universitaire de santé et des services sociaux de l'Est de l'Ile de Montréal-Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
ORCID-Profile: Pierre-Luc Gagnon, Nicolas Voizard, Véronique Caty
Zitieren
APA
Gagnon, P. L., Thérasse, É., Voizard, N., Dubé, M., & Caty, V. (2024). Uterine Fibroid Embolization Survey in Canada: Challenges, Opportunities, and Differences in Practices Across the Country. Canadian Association of Radiologists Journal. https://doi.org/10.1177/08465371241252307
Vancouver
Gagnon PL, Thérasse É, Voizard N, Dubé M, Caty V. Uterine Fibroid Embolization Survey in Canada: Challenges, Opportunities, and Differences in Practices Across the Country. Canadian Association of Radiologists Journal. 2024. doi:10.1177/08465371241252307
BibTeX
@article{Gagnon2024,
author = {Gagnon, Pierre-Luc and Thérasse, Éric and Voizard, Nicolas and Dubé, Michel and Caty, Véronique},
title = {Uterine Fibroid Embolization Survey in Canada: Challenges, Opportunities, and Differences in Practices Across the Country},
journal = {Canadian Association of Radiologists Journal},
year = {2024},
doi = {10.1177/08465371241252307}
}
EUVIMED